Influenza virus binding, sialylated oligosaccharide substance and use thereof
    2.
    发明授权
    Influenza virus binding, sialylated oligosaccharide substance and use thereof 失效
    流感病毒结合,唾液酸化寡糖物质及其用途

    公开(公告)号:US07902170B2

    公开(公告)日:2011-03-08

    申请号:US10311713

    申请日:2001-06-20

    摘要: The present invention is directed to human influenza virus binding substance containing at least one oligosaccharide chain, which comprises a terminal NeuNAcα6 linked to: (a) a linear or branched polylactosamine type structure consisting of at least three lactosamine residues, a linear sequence optionally containing one or two α3-linked fucose residues in a non-sialylated lactosamine, a branched structure optionally carrying one or more additional NeuNAcα-residues at a terminal position in a branch, and/or (b) a linear or branched structure with two lactosamine and one lactose residue, a linear structure in addition containing one or two α3-linked fucose residues in a non-sialylated lactosamine or lactose, a branched structure optionally carrying one additional NeuNAcα-residue in a terminal position of the branch, or an analog or derivative of said oligosaccharide chain for use in binding of human influenza virus.

    摘要翻译: 本发明涉及含有至少一个寡糖链的人流感病毒结合物质,其包含与以下连接的末端NeuNAcα6连接的末端NeuNAcα6:(a)由至少三个乳糖胺残基组成的直链或支链多聚乳糖胺型结构,任选地含有一个 或非唾液酸化乳糖胺中的两个α3连接的岩藻糖残基,任选地在支链末端携带一个或多个另外的NeuNAcα残基的支链结构和/或(b)具有两个乳糖胺和一个 乳糖残基,在非唾液酸化乳糖胺或乳糖中另外含有一个或两个α3连接的岩藻糖残基的线性结构,任选地在该分支的末端位置携带一个额外的NeuNAcα-残基的支链结构,或其衍生物 所述寡糖链用于人流感病毒的结合。